Development of a SARS‐CoV‐2 viral dynamic model for patients with COVID‐19 based on the amount of viral RNA and viral titer by Daichi Yamaguchi, Ryosuke Shimizu, Ryuji Kubota

Connect to this object online.

Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trial by Takuhiro Sonoyama, Ryosuke Shimizu, Ryuji Kubota, Yumiko Matsuo, Daiki Okutsu, Hideki Yamanaka, Keiko Takasu, Koichi Ogawa, Tomoko Motomiya

Connect to this object online.

Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. by Daisuke Kodama, Masakazu Tanaka, Toshio Matsuzaki, Kimiko Izumo, Nobuaki Nakano, Eiji Matsuura, Mineki Saito, Masahiro Nagai, Masahisa Horiuchi, Atae Utsunomiya, Hiroshi Takashima, Ryuji Kubota, Shuji Izumo

Connect to this object online.

Geographic characteristics of HTLV-1 molecular subgroups and genetic substitutions in East Asia: Insights from complete genome sequencing of HTLV-1 strains isolated in Taiwan and J... by Satoshi Nozuma, Akiko Yoshimura, Shun-Chung Pai, Hung-Jen Chen, Eiji Matsuura, Masakazu Tanaka, Daisuke Kodama, Mika Dozono, Toshio Matsuzaki, Hiroshi Takashima, Ya-Chien Yang, Ryuji Kubota

Connect to this object online.